|
gptkbp:instanceOf
|
gptkb:chemical_compound
recreational drug
|
|
gptkbp:CASNumber
|
15532-75-5
|
|
gptkbp:category
|
gptkb:piperazine
recreational drug
serotonergic agent
|
|
gptkbp:chemicalFormula
|
C11H15F3N2
|
|
gptkbp:color
|
white
|
|
gptkbp:compatibleWith
|
medical use
|
|
gptkbp:discoveredIn
|
1970s
|
|
gptkbp:effect
|
hallucinogenic
stimulant
entactogenic
|
|
gptkbp:form
|
gptkb:tablet
capsule
powder
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
TFMPP
|
|
gptkbp:IUPACName
|
gptkb:1-(3-trifluoromethylphenyl)piperazine
|
|
gptkbp:legalStatus
|
gptkb:Class_C_(United_Kingdom)
gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(United_States)
|
|
gptkbp:mainStreet
|
gptkb:Legal_X
gptkb:Trifly
gptkb:MFT
|
|
gptkbp:mechanismOfAction
|
serotonin receptor agonist
|
|
gptkbp:molecularWeight
|
230.25 g/mol
|
|
gptkbp:PubChem_CID
|
72119
CHEMBL2106062
|
|
gptkbp:routeOfAdministration
|
oral
insufflation
|
|
gptkbp:sideEffect
|
nausea
vomiting
anxiety
headache
insomnia
|
|
gptkbp:UNII
|
1E8F6J13KX
|
|
gptkbp:usedAs
|
recreational drug
|
|
gptkbp:usedFor
|
gptkb:BZP
|
|
gptkbp:bfsParent
|
gptkb:BZP
|
|
gptkbp:bfsLayer
|
7
|